Lung cancer perfusion at multi-detector row CT: reproducibility of whole tumor quantitative measurements.
暂无分享,去创建一个
Ernst Klotz | Vicky Goh | Heinz Fichte | H. Fichte | V. Goh | E. Klotz | A. Padhani | Q. Ng | P. Hoskin | Anwar R Padhani | Peter J Hoskin | M. Saunders | Quan-Sing Ng | Pat Fernie | Michele I Saunders | P. Fernie
[1] Kazuo Miyasaka,et al. Lung Tumors Evaluated With FDG-PET and Dynamic CT: The Relationship Between Vascular Density and Glucose Metabolism , 2002, Journal of computer assisted tomography.
[2] E. Fishman,et al. Application of CT in the investigation of angiogenesis in oncology. , 2000, Academic radiology.
[3] R. Craen,et al. Quantitative assessment of cerebral hemodynamics using CT: stability, accuracy, and precision studies in dogs. , 1999, Journal of computer assisted tomography.
[4] T. Purdie,et al. Functional CT imaging of angiogenesis in rabbit VX2 soft-tissue tumour. , 2001, Physics in medicine and biology.
[5] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[7] A. Padhani,et al. Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis , 2002, NMR in biomedicine.
[8] M. Dewhirst,et al. Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. , 1996, Cancer research.
[9] V. Goh,et al. Quantitative assessment of colorectal cancer perfusion using MDCT: inter- and intraobserver agreement. , 2005, AJR. American journal of roentgenology.
[10] K. Miles,et al. CT derived Patlak images of the human kidney. , 1999, The British journal of radiology.
[11] K. Miles,et al. CT measurements of capillary permeability within nodal masses: a potential technique for assessing the activity of lymphoma. , 1997, British Journal of Radiology.
[12] F R Verdun,et al. Using 80 kVp versus 120 kVp in perfusion CT measurement of regional cerebral blood flow. , 2000, AJNR. American journal of neuroradiology.
[13] J. Yap,et al. Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Martin A Lodge,et al. Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] J. Folkman,et al. Clinical translation of angiogenesis inhibitors , 2002, Nature Reviews Cancer.
[16] D. Altman,et al. Applying the right statistics: analyses of measurement studies , 2003, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[17] R. Craen,et al. A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps. , 2000, AJNR. American journal of neuroradiology.
[18] F. Eskens,et al. Angiogenesis inhibitors in clinical development; where are we now and where are we going? , 2004, British Journal of Cancer.
[19] K. Miles,et al. Standardized perfusion value: universal CT contrast enhancement scale that correlates with FDG PET in lung nodules. , 2001, Radiology.
[20] M. van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.
[21] Ricky T. Tong,et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.
[22] S. Hill,et al. Temporal heterogeneity in microregional erythrocyte flux in experimental solid tumours. , 1995, British Journal of Cancer.
[23] Weijing Sun,et al. Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] J. Heiserman,et al. Assessment of the reproducibility of postprocessing dynamic CT perfusion data. , 2004, AJNR. American journal of neuroradiology.
[25] C. Yi,et al. Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density. , 2004, Radiology.